Monday, October 3, 2016 | 1:30 PM - 4:30 PM
Speakers: Marcin Imielinski (Weill Cornell Medicine), Christopher Lima (Memorial Sloan Kettering Cancer Center), Barry Sleckman (Weill Cornell Medicine), Alexandra Zidovska (New York University)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
Tuesday, October 25, 2016 | 9:00 AM - 5:00 PM
Speakers: Marcus Bantscheff (Cellzome/GSK), Benjamin F Cravatt (The Scripps Research Institute), Craig Crews (Yale University), Howard Hang (The Rockefeller University), Ruth Nussinov (National Cancer Institute), Brian Raymer (Pfizer), Bryan Roth (University of North Carolina), Eranthie Weerapana (Boston College)
Chemical Biology is changing the face of drug discovery. This symposium will highlight recent developments in the field, featuring examples from neurobiology and cancer, the ubiquitin proteasome system, GPCRs, and protein lipidation.
Thursday, November 10, 2016 | 8:00 AM - 6:00 PM
Speakers: Iannis Aifantis (NYU School of Medicine), Emily Bernstein (Icahn School of Medicine at Mount Sinai), Ryan Kruger (GlaxoSmithKline), Ross L. Levine (Memorial Sloan Kettering Cancer Center), Sheng Li (Weill Cornell Medical College), Christopher E. Mason (Weill Cornell Medicine), Kornelia Polyak (Dana Farber Cancer Institute, Harvard Medical School), Tim Somervaille (The University of Manchester), and Jorge DiMartino (Celgene)
This conference will explore novel target and validation strategies, translational approaches to assess predictive and response biomarkers, resistance mechanisms, and combination strategies for targeting epigenetic susceptibilities in cancer.
Tuesday, November 15, 2016 | 9:00 AM - 5:00 PM
Speakers: Thaddeus Stappenbeck (Washington University School of Medicine), Declan F. McCole (University of California, Riverside), Jerrold R. Turner (Harvard Medical School), Linda G. Griffith (MIT), Tim Denning (Georgia State University), and Alan Hanash (Memorial Sloan Kettering Cancer Center)
This symposium will evaluate emerging research investigating the benefits of achieving mucosal healing in the treatment of intestinal disorders.
Friday, December 2, 2016 | 12:30 PM - 6:30 PM
Speakers: Jan van Deursen (The Mayo Clinic), Vadim Gladyshev (Harvard University), Steven Horvath (University of California Los Angeles), Matt Kaeberlein (University of Washington), Vera Gorbunova (University of Rochester), and Arlan Richardson (University of Oklahoma)
To explore the interplay between aging, nutrition, and metabolism, as well as the important role that novel technologies will play in current and future studies, we are bringing together several preeminent researchers in these fields.
Thursday, September 22, 2016 | 8:00 AM - 2:15 PM
Featuring: Yoshinori Ohsumi (Tokyo Institute of Technology)
The 2016 Dr. Paul Janssen Award Symposium will honor Dr. Yoshinori Ohsumi for his groundbreaking research demonstrating that autophagy is a crucial process in maintaining cellular homeostasis as well as establishing its role in human health.
September 21 - 23, 2016
Featuring: Peder S. Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)
Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.
Friday, September 9, 2016 | 12:00 PM - 4:00 PM
Speakers: Yael David (MSKCC), Shohei Koide (NYU Langone Medical Center), Alexander J. Kasznel (University of Pennsylvania), Jonathan R. Lai (Albert Einstein College of Medicine), Jim Wells (University of California San Francisco), and Manoj Charati (Pfizer)
This symposium will highlight state-of-the-art technologies in protein and antibody engineering, and antibody-drug conjugates. The implementation of these methods to specific diseases, and unique research tools, will also be discussed.
Thursday, September 8, 2016 | 9:00 AM - 5:00 PM
Speakers: Hans-Joachim Anders (University of Munich), John Cijiang He (Icahn School of Medicine at Mount Sinai), Matthias Kretzler (University of Michigan), Kevin V. Lemley (University of Southern California), Jochen Reiser (Rush University Medical Center), Myung K. Shin (Merck & Co. Inc.), Katalin Susztak (University of Pennsylvania), and Roger C. Wiggins (University of Michigan)
Accumulating evidence supports a role for renal inflammation and podocytopathy in pathogenesis and progression of chronic kidney disease. This symposium will delve into the mechanisms underlying this pathology.
Edited by Mone Zaidi
(Mount Sinai School of Medicine, New York, New York)
Original research and review manuscripts covering topics in basic and translational bone and bone marrow biology.
Keynote Speakers: Richard Gilbertson (Cambridge Cancer Centre, University of Cambridge, UK) and Craig B. Thompson (Memorial Sloan Kettering Cancer Center)
This eBriefing covers the latest research on pediatric cancers.
Organizers: Donald McCaffery (Resverlogix Corp.), Norman Wong (Resverlogix Corp.), Sarah Zapotichny (Resverlogix Corp.), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)
Epigenetic abnormalities contribute to tumorigenesis and various diseases beyond cancer. This eBriefing describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetic marks.
Edited by Annals of the New York Academy of Sciences
This Annals issue presents a meeting report on mobile health technology in clinical trials and five original research articles discussing topics related to β-thalassemia major, Alzheimer's disease, hematopoiesis, hepatosteatosis, and downbeat nystagmus.